Ibuprofen is an NSAID that can affect kidney function, particularly in people with diabetes who may have pre-existing renal impairment
The trial program has evolved from glycemic-safety and outcomes studies in T2D (the LEADER, SUSTAIN-6, REWIND, EXSCEL, and PIONEER 6 era [10][13], [19]), to outcomes trials in expanded populations including obesity without diabetes (SELECT [3]), HFpEF with obesity (SUMMIT [5], with a companion semaglutide program in STEP-HFpEF [20], [21]), CKD (FLOW [22]), and an active-comparator setting (SURPASS-CVOT [6])
The 38-year-old Arlington, Virginia, real estate agent said she gained 30 pounds during the pandemic, and was drinking more too
There is some intriguing evidence that GLP-1 may actually reduce bloating in the long run by improving gut transit regularity and reducing intestinal inflammation
DPP-4 inhibitory properties were discovered in nine of these compounds